Fineotex Chemical Limited · NSE:FCL

Fineotex Chemical — Q1 FY2021 Earnings Presentation

19 slides from Fineotex Chemical's earnings presentation, Jul 28, 2020

  1. Slide 1: Fineotex Chemical Limited exchange submission letter

    FINEOTEX® A Speciality Chemical Producing Public Listed Company pitt &ee (~---)) (F2) 180) 59); STN ee OR * Qa” 8014001 — ann 9 54 gq0° ~ 28" July, 2020 To, General Manager, The Manager, Listing Department, Listing & Compliance Department BSE Limited, The National Stock Exchange of India Limited P.J

  2. Slide 2: Q1 FY2021 Earnings Presentation

    Fineotex Chemical Limited (BSE: 533333; NSE: FCL) Q1 FY2021 Earnings Presentation Drilling Specialties Textile Specialties Home Care and Hygiene Specialties Other Specialties

  3. Slide 3: Fineotex Investment Case

    Fineotex Investment Case Diversified business – top 10 customers contribute to ~33% of sales and top 10 products contribute to ~18% of sales Management proven acquisition track record: Biotex (73% owned) net profit has grown by a factor of 4x since acquisition in 2011 and de- leveraged into a debt f

  4. Slide 4: Key Themes: Q1 FY2021

    Key Themes: Q1 FY2021 • Consolidated profit after tax of Rs. 82.0 mn, up 42.5% Financial Performance • Standalone profit after tax of Rs. 64.8 mn, up 38.6% • Fineotex continues to optimise operating costs in a challenging business environment • Supplier to civic authorities and private hospitals in

  5. Slide 5: Consolidated Financial Highlights: Q1 FY2021 (Y-o-Y)

    Consolidated Financial Highlights: Q1 FY2021 (Y-o-Y) Rs 303.9 mn Rs 41.1 mn Rs 82.0 mn Performance Discussion: Total Revenue EBITDA Net Profit • Q1 FY2021 Revenue was as expected impacted by the outbreak of COVID-19, resulting in lower business activity • Our factories resumed business operations at

  6. Slide 6: Chairman’s Message

    Chairman’s Message “ During testing times post the outbreak of COVID-19, we delivered resilient operating performance in Q1 FY2021. Operations were impacted across our facilities in India and Malaysia since the government authorities announced stringent lockdown measures in March and April. Our oper

  7. Slide 7: Strategic Direction

    Strategic Direction Continue to leverage Fineotex’s industry insights and long standing customer relationships with Fineotex + Biotex Synergies Biotex’s high end product expertise and regional positioning. An integrated compelling value proposition for all global customers Enter fast growing synergi

  8. Slide 8: Synergistic Business Model

    Synergistic Business Model Fineotex - India Biotex - Malaysia • Diverse product portfolio (400+ categories) • Niche portfolio (50+ products categories) across business segments Overview • High end super speciality textile chemical • Applications primarily across the entire textile applications value

  9. Slide 9: New Growth Areas

    New Growth Areas Home Care and Hygiene Chemicals Drilling Speciality Chemicals Other Speciality Chemicals • Customised solutions for: • Customised solutions for: • Aquastrike VCF ▪ FMCG - branded detergents ▪ Oil and Gas • Customised solutions for: ▪ Public Health and Hygiene ▪ Agrochemicals and Fer

  10. Slide 10: Specialty Textile Chemicals Overview

    Specialty Textile Chemicals Overview Steps Weaving Pre-treatment Dyeing Printing Finishing De-sizing, Dyeing, Rotary Exhaust Process Sizing Scouring, Washing, Printing, Padding Bleach Fixing Table Printing Enzymes, Dyes, Acids, Dyes, Binder Softeners, Wetting & Alkali Thickener, Fixer Product Polyme

  11. Slide 11: Global Customer Reach

    Global Customer Reach • Sales in 60+ countries including Brazil, Bangladesh, Germany, Indonesia, Malaysia, Singapore, Thailand, USA and Vietnam • 30+ technical marketing experts • 100+ dealers in Indian and International markets FY20 Revenue Mix 52% 48% Facility at Mahape, Mumbai, India Fineotex Top

  12. Slide 12: Manufacturing Platforms (GMP Certified)

    Manufacturing Platforms (GMP* Certified) Location Operating Facts Strategic Advantages Manufacturing Excellence • Production Capacity: • Centrally located plant with 36,500 MT p.a. logistical advantage to key textile hubs across North, West, South • Utilisation: 56% and Central India Navi Mumbai, In

  13. Slide 13: Board of Directors

    Board of Directors Surendrakumar Tibrewala Sanjay Tibrewala Aarti Jhunjhunwala Chairman and Managing Director Executive Director and CFO Executive Director Navin Mittal Manmohan Mehta Alok Dhanuka Bindu Shah Independent Director Independent Director Independent Director Independent Director Audit Co

  14. Slide 14: Consolidated P&L Summary: Q1 FY2021

    Consolidated P&L Summary: Q1 FY2021 (Rs. Million) Q1 FY21 Q1 FY20 YoY% Q4 FY 20 QoQ% FY 20* FY 19 YoY% Revenue from Operations 303.9 496.5 (38.8%) 435.8 (30.3%) 1,963.4 1,823.3 7.7% COGS 209.7 319.2 (34.3%) 265.5 (21.0%) 1,231.4 1,175.9 4.7% Gross Profit 94.2 177.4 (46.9%) 170.3 (44.7%) 731.9 647.3

  15. Slide 15: Consolidated Quarterly Performance Trend

    Consolidated Quarterly Performance Trend Figures in Rs. Mn. Revenue from Operations and Gross Margin EBITDA and EBITDA Margin 39.1% 19.8% 38.1% 36.5% 17.1% 17.1% 17.4% 35.7% 15.4% 31.0% 497 510 521 101 436 85 80 76 304 41 Q1 FY 20 Q2 FY 20 Q3 FY 20 Q4 FY 20 Q1 FY 21 Q1 FY 20 Q2 FY 20 Q3 FY 20 Q4 FY

  16. Slide 16: Consolidated Annual Performance Trend

    Consolidated Annual Performance Trend Figures in Rs. Mn. Revenue from Operations and Gross Margin EBITDA and EBITDA Margin CAGR: 14.0% 21.9% CAGR: 15.7% 44.5% 21.0% 42.1% 40.3% 19.0% 25.2% 17.4% 35.5% 37.3% 16.2% 33.1% 1,963 347 342 1,823 277 295 300 1,344 1,429 1,020 1,099 165 FY 15 FY 16 FY 17 FY

  17. Slide 17: Consolidated Balance Sheet and Return Ratios Trend

    Consolidated Balance Sheet and Return Ratios Trend Figures (in Rs Mn) Mar-19 Mar-20 Cash Flow from Operations /EBITDA (%) ST Debt 20 28 83% 83% LT Debt 1 - 65% Total Debt 21 28 49% Cash & Cash Equivalent 147 179 35% Net Cash 127 151 21% Equity 1,652 1,760 Total debt/Equity 0.01x 0.02x FY 15 FY 16 FY

  18. Slide 18: Disclaimer

    Disclaimer This presentation contains statements that contain “forward looking statements” including, but without limitation, statements relating to the implementation of strategic initiatives, and other statements relating to Fineotex Chemical Limited (“Fineotex Chemical” or the Company) future bus

  19. Slide 19: Fineotex Chemical Limited

    Fineotex Chemical Limited FINEOTEX CHEMICAL LIMITED (CIN Number: L24100MH2004PLC144295) 42-43, Manorama Chambers, S. V. Road Bandra (West), Mumbai - 400 050, India Phone: (+91 - 22) 26559174 / 75, (+91 - 22) 26559176 / 77 Email: info@fineotex.com www.fineotex.com 18

Fineotex Chemical — Q1 FY2021 Earnings Presentation on 6ix